Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Canadian Cancer Trials Group ( NCIC Clinical Trials Group )
ClinicalTrials.gov Identifier:
NCT00095992
First received: November 9, 2004
Last updated: September 26, 2011
Last verified: September 2011